Please sign in to follow a disease.
Could a placental wrap help men recover erections faster after prostate cancer surgery?
NCT ID NCT05842057
First seen Jul 14, 2026 · Last updated Jul 15, 2026 · Updated 1 time
Summary
This trial tests whether placing a dehydrated human amnion chorion membrane (dHACM) over the nerves during robot-assisted prostate removal helps men recover erectile function and urinary control sooner. The study enrolls men aged 40 to 80 with localized prostate cancer who have good erectile function before surgery. The membrane is a placental tissue allograft placed over the nerves on each side of the prostate.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- a dehydrated human amnion chorion membrane (dHACM) placed over nerves during prostate surgery
- What this could lead to
- If it works, this could offer a way to speed up recovery of erectile function and urinary control after prostate cancer surgery.
- What could go wrong
- This is a mid-stage trial with 118 men, so results are not yet proven. The membrane may not improve recovery, and there are risks from surgery itself.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Phase 2
Tests whether the treatment actually works, and watches for side effects, in a larger group.
- Participants
-
118 people
The number who actually took part.
- Started
-
Aug 2023
- Expected to finish
-
Aug 2028
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
40 to 80 years
- Sex
-
Male participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1\. Men aged 40 to 80 years with localized prostate cancer who are undergoing RARP at the University of Miami (UM). Exclusion Criteria: 1. Men requiring the use of any non-oral erectile aids for erectile dysfunction (ED). 2. Men with baseline EPIC26 scores \< 50. 3. Patients with complete, bilateral nerve resection. 4. Previous treatment for prostate cancer. 5. Previous history of pelvic radiation. 6. Patients with impaired decision-making capacity.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Erectile dysfunction following radical prostatectomy are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Miami
Miami, Florida, 33136, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- RE-irradiation for isolated FOCal recurrence of prostate cancer with ultrahypofracted SBRT: the RE-FOCUS study - pushing the boundaries of precision and efficacy
- A sharper eye for cancer: new PET tracer targets hidden tumors
- Can a radioactive tracer help surgeons find hidden prostate cancer?
- Steam therapy vs. surgery: can a less invasive fix help men with blocked urine flow?
- Can smart fluid monitoring improve robotic prostatectomy outcomes?
- Smart blood pressure monitoring may shield kidneys during robotic surgery